Acarix Q2 2024: Initial take – soft revenues but good cost control - Redeye

Redeye views Acarix's Q2 as weaker than anticipated, with lower-than-expected revenues. However, the company's ongoing cost-cutting measures positively impacted results, making the EBIT deviation relatively modest. We anticipate making downward revisions to our forecasts and fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1032051/acarix-q2-2024-initial-take-soft-revenues-but-good-cost-control?utm_source=finwire&utm_medium=RSS